Pharmacy News EU

"To evaluate the maternal and perinatal outcome following expectant management of early-onset severe preeclampsia (PE) at a tertiary hospital in Mansoura, Egypt. This prospective, observational study included 211 patients with severe PE, occurring between 24 and 34 weeks of gestation," researchers in Mansoura, Egypt report (see also Obstetrics and Gynecology)."They were classified according to gestational [...]

A report, ‘Octogenarians undergoing combined aortic valve replacement and myocardial revascularization: perioperative mortality and medium-term survival,’ is newly published data in The Thoracic and Cardiovascular Surgeon. According to a study from Giessen, Germany, "Aim of the study was to answer the question whether the mortality and morbidity of octogenarians undergoing combined aortic valve replacement and [...]

STOCK MARKETING INC PRESENTS : (OTCBB: VKNG) Viking Systems, Inc., (OTCBB: CBAI) Cord Blood America, Inc., (OTCBB: NPHC) Nutra Pharma Corp., (OTCBB: BOCX) BioCurex, Inc., (OTCBB: WPUR) WaterPure International, Inc., (OTCBB: DTRO) Deltron, Inc.www.StockMarketingInc.comFor More Information email us!! Steve@StockMarketingInc.com
(OTCBB: VKNG – Viking Systems, Inc.)LATEST NEWS!!Viking Systems and Boston Scientific Extend Supply ContractWESTBOROUGH, Mass., Jul 28, [...]

Fresh data on pharmacological are presented in the report ‘Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany.’ "Objectives Patients’ self-report of medicine taking is a feasible method of assessing their adherence to prescribed pharmacological treatment. Aim of this study was to assess whether the [...]

Researchers detail in ‘Pityriasis rubra pilarisa retrospective single center analysis over eight years,’ new data in pityriasis rubra pilaris. "Pityriasis rubra pilaris (PRP) is a rare papulosquamous dermatosis. We evaluated evaluate co-morbidities, complications, and outcome of treatment regimens," researchers in Dresden, Germany report (see also Pityriasis Rubra Pilaris)."This is a retrospective study at an academic [...]

Investigators publish new data in the report ‘Pharmacoepidemiology of patients hospitalized for somatoform disorders in psychiatric hospitals and departments.’ "Pharmacological treatment is used in patients with somatoform disorders (SD) although the empirical evidence is scarce. We evaluated the current pharmacological treatment strategies used for psychiatric in-patients diagnosed with SD in Central Europe," researchers in Germany [...]

A new study, ‘Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts,’ is now available. According to recent research from Barcelona, Spain, "Platelets activated during experimental acute myocardial infarction (AMI) contribute to myocardial injury. This study aimed to investigate whether platelets from patients with AMI increase [...]

Researchers detail in ‘Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial,’ new data in venous thrombosis. According to recent research published in the journal Thrombosis and Haemostasis, "Standard treatment with heparin followed by vitamin K antagonists is frequently complicated by [...]

Research findings, ‘Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer,’ are discussed in a new report. According to a study from Munich, Germany, "For definitive radiochemotherapy, 5-fluorouracil/cisplatin protocols have been considered the standard of care for esophageal carcinoma over the last 2 decades. By contrast, most patients treated at the University [...]

GENEVA, Switzerland, July 28, 2010 /PRNewswire/ Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announcedtoday that the U.S. Food and Drug Administration (FDA) has accepted forfiling the New Drug Application (NDA) for Cladribine Tablets as a therapy forrelapsing forms of multiple sclerosis (MS).
The application also has been granted a [...]